After a short experiment with a grey font, Textise now defaults to a black 16px font. If you'd like to change the font colour, or make other modifications, please visit the Options page.


This page has been Textised!
The original page address was https://noharm-europe.org/issues/europe/edcs


Advanced
Search »
 
Advanced Search
E.g., 06/25/2018
E.g., 06/25/2018
[Image: Homepage]   Text
Only
  Somente
texto
  Solo
texto
 
Make a Donation
Menu
             
You are here
  1. Home
  2. Issues
  3. EDCs
EDCs

Medical devices play a critical role in healthcare. But many medical devices contain hazardous substances in their composition that can leach out into patients dring their use, compromising patient safety. One particularly hazardous group of such substances are endocrine disrupting chemicals (EDCs). These chemicals interfere with the normal functioning of the endocrine system and present a hazard to different physiological and developmental processes. The most common EDCs found in healthcare and medical devices are phthalates and Bisphenol A (BPA). Phthalates are commonly used as softeners in PVC-based medical devices while BPA is used in a variety of plastics with many applications in the medical device industry. Learn more from our infographic:

 


Health Care Without Harm Europe works to educate the healthcare sector about the harm of EDCs in medical devices, promote safer alternatives, and to lobby for changes to EU legislation that would phase out harmful substances where safer substitutes exist. Safer alternatives for almost all medical devices are available on the market and are already used by many healthcare institutions in Europe, and procurement decisions relating to medical devices often come down to knowledge, price and legal context.

Visit our EDC resources page for more information about EDCs.



Textise: Back to top

This text-only page was created by Textise (www.textise.net). Copyright Subjunctive Software.
Find us on Facebook and Twitter or visit the Official Blog.